Anti-CAPS monoclonal antibody

Pre-made anti-CAPS monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to CAPS/CAPS products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2396-Ab-1/ GM-Tg-hg-IP2396-Ab-2Anti-Human CAPS monoclonal antibodyHuman
GM-Tg-rg-IP2396-Ab-1/ GM-Tg-rg-IP2396-Ab-2Anti-Rat CAPS monoclonal antibodyRat
GM-Tg-mg-IP2396-Ab-1/ GM-Tg-mg-IP2396-Ab-2Anti-Mouse CAPS monoclonal antibodyMouse
GM-Tg-cynog-IP2396-Ab-1/ GM-Tg-cynog-IP2396-Ab-2Anti-Cynomolgus/ Rhesus macaque CAPS monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2396-Ab-1/ GM-Tg-felg-IP2396-Ab-2Anti-Feline CAPS monoclonal antibodyFeline
GM-Tg-cang-IP2396-Ab-1/ GM-Tg-cang-IP2396-Ab-2Anti-Canine CAPS monoclonal antibodyCanine
GM-Tg-bovg-IP2396-Ab-1/ GM-Tg-bovg-IP2396-Ab-2Anti-Bovine CAPS monoclonal antibodyBovine
GM-Tg-equg-IP2396-Ab-1/ GM-Tg-equg-IP2396-Ab-2Anti-Equine CAPS monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2396-Ab-1/ GM-Tg-hg-IP2396-Ab-2; GM-Tg-rg-IP2396-Ab-1/ GM-Tg-rg-IP2396-Ab-2;
GM-Tg-mg-IP2396-Ab-1/ GM-Tg-mg-IP2396-Ab-2; GM-Tg-cynog-IP2396-Ab-1/ GM-Tg-cynog-IP2396-Ab-2;
GM-Tg-felg-IP2396-Ab-1/ GM-Tg-felg-IP2396-Ab-2; GM-Tg-cang-IP2396-Ab-1/ GM-Tg-cang-IP2396-Ab-2;
GM-Tg-bovg-IP2396-Ab-1/ GM-Tg-bovg-IP2396-Ab-2; GM-Tg-equg-IP2396-Ab-1/ GM-Tg-equg-IP2396-Ab-2
Products NameAnti-CAPS monoclonal antibody
Formatmab
Target NameCAPS
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-CAPS monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2396-Ag-1Recombinant multi-species CAYP1/ CAPS/ CAPS1 protein
    ORF Viral VectorpGMLV000249human CAPS Lentivirus plasmid
    ORF Viral VectorvGMLV000249human CAPS Lentivirus particle


    Target information

    Target IDGM-IP2396
    Target NameCAPS
    Gene ID828,120094827,700767,403965,101094401,616482,100065259
    Gene Symbol and SynonymsCAPS,CAPS1
    Uniprot AccessionQ13938,P10463,Q0VCC0
    Uniprot Entry NameCAYP1_HUMAN,CAYP1_CANLF,CAYP1_BOVIN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000105519
    Target ClassificationTumor-associated antigen (TAA)

    The target: CAPS, gene name: CAPS, also named as CAPS1. This gene encodes a calcium-binding protein, which may play a role in the regulation of ion transport. A similar protein was first described as a potentially important regulatory protein in the dog thyroid and was termed as R2D5 antigen in rabbit. Alternative splicing of this gene generates two transcript variants. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.